Literature DB >> 10677166

Surgical management of primary colorectal cancer.

L Ruo1, J G Guillem.   

Abstract

Surgery for potentially curable colorectal cancer most commonly involves resection of the primary tumor and regional lymph nodes. However, the site, extent and presentation of disease have an impact on surgical strategy and the use of combined modality therapy. For colon cancer, complex presentations such as obstructing or perforated colon cancer may influence surgical therapy, and issues pertaining to en bloc resection and oophorectomy remain unresolved. For rectal cancer, surgical management may range from local excision to radical resection. Extent of resection and relatively new operative techniques such as coloanal anastomosis with or without a colonic pouch reservoir are directed towards optimizing both oncologic and functional results.

Entities:  

Mesh:

Year:  1998        PMID: 10677166     DOI: 10.1016/s0960-7404(99)00033-x

Source DB:  PubMed          Journal:  Surg Oncol        ISSN: 0960-7404            Impact factor:   3.279


  5 in total

1.  Fluorescence-guided surgery of human colon cancer increases complete resection resulting in cures in an orthotopic nude mouse model.

Authors:  Cristina A Metildi; Sharmeela Kaushal; Cynthia S Snyder; Robert M Hoffman; Michael Bouvet
Journal:  J Surg Res       Date:  2012-09-07       Impact factor: 2.192

2.  Successful fluorescence-guided surgery on human colon cancer patient-derived orthotopic xenograft mouse models using a fluorophore-conjugated anti-CEA antibody and a portable imaging system.

Authors:  Yukihiko Hiroshima; Ali Maawy; Cristina A Metildi; Yong Zhang; Fuminari Uehara; Shinji Miwa; Shuya Yano; Sho Sato; Takashi Murakami; Masashi Momiyama; Takashi Chishima; Kuniya Tanaka; Michael Bouvet; Itaru Endo; Robert M Hoffman
Journal:  J Laparoendosc Adv Surg Tech A       Date:  2014-02-04       Impact factor: 1.878

3.  Fluorescently labeled chimeric anti-CEA antibody improves detection and resection of human colon cancer in a patient-derived orthotopic xenograft (PDOX) nude mouse model.

Authors:  Cristina A Metildi; Sharmeela Kaushal; George A Luiken; Mark A Talamini; Robert M Hoffman; Michael Bouvet
Journal:  J Surg Oncol       Date:  2013-11-19       Impact factor: 3.454

4.  Impact of cytokeratin-20 and carcinoembryonic antigen mRNA detection by RT-PCR in regional lymph nodes of patients with colorectal cancer.

Authors:  R Rosenberg; A Hoos; J Mueller; H Nekarda
Journal:  Br J Cancer       Date:  2000-11       Impact factor: 7.640

Review 5.  Precision Medicine for CRC Patients in the Veteran Population: State-of-the-Art, Challenges and Research Directions.

Authors:  Shyam S Mohapatra; Surinder K Batra; Srinivas Bharadwaj; Michael Bouvet; Bard Cosman; Ajay Goel; Wilma Jogunoori; Michael J Kelley; Lopa Mishra; Bibhuti Mishra; Subhra Mohapatra; Bhaumik Patel; Joseph R Pisegna; Jean-Pierre Raufman; Shuyun Rao; Hemant Roy; Maren Scheuner; Satish Singh; Gitanjali Vidyarthi; Jon White
Journal:  Dig Dis Sci       Date:  2018-03-23       Impact factor: 3.199

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.